Venus Concept Inc is a medical technology company... Show more
The 10-day RSI Indicator for VERO moved out of overbought territory on April 10, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on April 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VERO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for VERO turned negative on April 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
VERO moved below its 50-day moving average on April 16, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VERO crossed bearishly below the 50-day moving average on April 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
VERO broke above its upper Bollinger Band on April 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where VERO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERO advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.623) is normal, around the industry mean (24.089). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.044) is also within normal values, averaging (42.249).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VERO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
a medical aesthetic technology company
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CSGIX | 10.35 | 0.10 | +0.98% |
Calamos International Small Cap Gr I | |||
GIIZX | 13.13 | 0.09 | +0.69% |
GuideStone Funds Intl Eq Idx Investor | |||
SAGAX | 51.62 | 0.29 | +0.56% |
Virtus Zevenbergen Innovative Gr Stk A | |||
PWJDX | 32.28 | 0.06 | +0.19% |
PGIM Jennison International Opps R4 | |||
CBEAX | 10.15 | N/A | N/A |
Allspring Large Cap Value CL A |
A.I.dvisor indicates that over the last year, VERO has been loosely correlated with RVTY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VERO jumps, then RVTY could also see price increases.
Ticker / NAME | Correlation To VERO | 1D Price Change % | ||
---|---|---|---|---|
VERO | 100% | +0.41% | ||
RVTY - VERO | 33% Loosely correlated | -1.78% | ||
ANSLY - VERO | 33% Loosely correlated | +6.74% | ||
CRL - VERO | 32% Poorly correlated | -1.82% | ||
ISRG - VERO | 32% Poorly correlated | N/A | ||
ATR - VERO | 32% Poorly correlated | -0.03% | ||
More |